P-147 Outcome of second-line chemotherapy (CT2) after first-line CT (CT1) with platinum plus gemcitabine in advanced biliary tract cancer (aBTC): is it worthwhile?

Authors :: Stefano Cereda
G. Aprile
Gianna Musettini
M. Milella
Francesco Leone
Giulia Pasquini
Daniele Santini
Giovanni Brandi
N. Silvestris
Caterina Vivaldi
S. Lonardi
Enrico Vasile
Chiara Caparello
L. Fornaro
Source :: Annals of Oncology. 26:iv42
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
medicine.medical_specialty
Biliary tract cancer
business.industry
First line
Hematology
Chemotherapy regimen
Second line chemotherapy
Gemcitabine
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools